Editorial: Exploiting non-oncogene addiction for overcoming drug resistance in metastatic tumors

Read full text Summarise with VIRAT
Authors: Albrecht Reichle, Dennis Christoph Harrer, Florian Lüke, Tobias Pukrop, Lina Ghibelli, Daniel Heudobler, :unav
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Editorial on the Research Topic Exploiting non-oncogene addiction for overcoming drug resistance in metastatic tumors Acquired genetic aberrations implement new information about how tissue systems should perform (Mueller et al. 2018; Hendrix et al. 2007). Emerging tumor systems integrate oncogene-driven information by coordinating vast networks of non-oncogenes within tumor and heterogeneous adjacent stroma cells, ultimately organizing non-oncogene addiction (NOA)-driven circuitries to ensure the viability and resilience of malignant tissues (Xu et al. 2024; Blazquez et al. 2020). Integrated oncogenic-triggered information, promoting NOA genome editing, becomes conceivable in novel tissue structures and functions. However, phenomenology does not reveal how oncogenic input is integrated transcriptionally, particularly with regard to the operation of novel oncogene-driven NOA circuitries that span tumor tissue systems (Yuan et al. 2024). The reproducibility of tumor phenomenology, which facilitates traditional tumor classification, hypothesizes that similar integration of oncogenic data is associated with a distinct input of oncogenic information. However, how is oncogenic information integration formally structured at the non-oncogene level? All five papers focus on the tension between oncogenic information input and comprehensive integration of non-oncogenes. Di Marco describes Coatomer subunit zeta-1 (COPZ1), a protein exhibiting characteristics of NOA in multiple tumor types. Its expression may be normal or increased compared to non-malignant cells. COPZ1 is genome-agnostically integrated across many tumor histologies (Di Marco et al.). Knockdown of COPZ1 leads to tumor cell death in various neoplasias. Silencing COPZ1 can involve Golgi damage, blocking autophagy or the unfolded protein response, silencing the type I interferon pathway, or

Fields of Study & Subjects

Cancer Genomics and Diagnostics Lung Cancer Treatments and Mutations Cancer Cells and Metastasis

Publication details

Journal / source
Fraunhofer-Publica (Fraunhofer-Gesellschaft)
Publication date
1 January 2026
Language
EN